Position in RPRX
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$6,808,429
+$1,333,374 QoQ
Shares Held
141,931
+0.2% QoQ
Ownership
0.025%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2021
9 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in RPRX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026CREDIT AGRICOLE S A holds $177,317,280 across 28 Biotechnology names. RPRX ranks #5 (3.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
92,416 | $71,404,297 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
122,365 | $54,640,866 | |
| 3 | MRNA |
Moderna, Inc.
|
200,797 | $10,200,487 | |
| 4 | INCY |
Incyte Corp
|
75,175 | $7,075,469 | |
| 5 | RPRX |
Royalty Pharma plc
This page
|
141,931 | $6,808,429 | |
| 6 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
11,751 | $3,888,052 | |
| 7 | KRYS |
Krystal Biotech, Inc.
|
12,976 | $3,351,960 | |
| 8 | JAZZ |
Jazz Pharmaceuticals plc
|
16,928 | $3,200,238 |
All Filings in RPRX
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $6,808,429 | 141,931 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $5,475,055 | 141,694 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $5,126,924 | 145,321 | Shares | Defined | 2025-11-14 | |
| 2025-03-31 | $3,895,296 | 125,130 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $177,192 | 6,946 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $84,870 | 3,000 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $870,210 | 33,000 | Shares | Defined | 2024-08-13 | |
| 2021-12-31 | $39,850 | 1,000 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $36,140 | 1,000 | Shares | Defined | 2021-11-15 | |
| No filing history on record for this holder in this stock. | ||||||